Stryker Corp Stock Price, News & Analysis

Stryker (NYSE:SYK) has scheduled its 2022 Annual Meeting of Shareholders for May 4, 2022, at 9:30 a.m. ET. The meeting will be held virtually, with details available on the Investor Relations page of the company's website. Shareholders can listen in by calling specified numbers. A recording of the meeting will be accessible starting May 5, 2022, until the filing of the definitive proxy statement for the 2023 meeting. Stryker is known for its innovative medical technology solutions across various specialties, aimed at improving healthcare outcomes.

Vocera Communications, Inc. announced a change following its acquisition by Stryker Corporation (NYSE: SYK). As of February 23, 2022, a Fundamental Change has occurred under the indentures governing Vocera’s 1.50% Convertible Senior Notes due 2023 and 0.50% Convertible Senior Notes due 2026. Noteholders can repurchase their Notes for cash at a price of 100% of the principal amount and accrued interest by March 25, 2022. Additionally, noteholders can convert their Notes at an increased rate until March 25, 2022. The Paying Agent is U.S. Bank Trust Company.

Stryker has successfully completed its acquisition of Vocera Communications for $79.25 per share, finalizing the tender offer that expired on February 22, 2022. Approximately 85% of Vocera's outstanding shares were tendered. This acquisition will enhance Stryker's digital healthcare offerings, promoting safer patient care. The financial impact on Stryker's net earnings per diluted share is projected to be neutral in 2022. Following the acquisition, Vocera will become a wholly owned subsidiary and will be delisted from the NYSE.

Stryker (NYSE:SYK) will participate in the Cowen 42^nd Annual Health Care Conference on March 7, 2022. Vice President and CFO Glenn Boehnlein will present virtually at 10:30 a.m. Eastern Time. Interested parties can access a live webcast and replay on Stryker's official website, which will be archived for future viewing. Stryker, a leader in medical technology, aims to enhance healthcare through innovative products and services in diverse areas, including Medical and Surgical, Neurotechnology, Orthopaedics, and Spine.

Stryker (NYSE:SYK) has declared a quarterly dividend of $0.695 per share, set to be paid on April 29, 2022, to shareholders recorded as of March 31, 2022. This marks a 10.3% increase compared to the previous year and remains unchanged from the last quarter. As a leader in medical technology, Stryker is committed to enhancing healthcare through innovative products and services, improving patient and hospital outcomes. For further details, visit www.stryker.com.

Stryker reported strong financial results for Q4 and full year 2021, with net sales up 10.3% year-over-year to $4.7 billion and 19.2% for the year to $17.1 billion. Organic sales rose 9.0% and 12.6% respectively. However, adjusted EPS decreased 3.6% to $2.71. Full-year operating income margin expanded to 25.6%. The company anticipates organic sales growth in 2022 of 6% to 8% despite potential pricing pressures and the ongoing impact of the COVID-19 pandemic.

Stryker (NYSE:SYK) announced a cash tender offer to acquire all outstanding shares of Vocera Communications, Inc. (NYSE:VCRA) for $79.25 per share, initiated on January 25, 2022. This offer follows a merger agreement dated January 6, 2022, and is scheduled to expire on February 22, 2022. The acquisition is contingent on various conditions, including a minimum tender of a majority of Vocera’s shares and regulatory approvals. Vocera's Board of Directors has recommended that its stockholders accept the tender offer. The transaction is expected to close in the first quarter of 2022.

Stryker (NYSE: SYK) has entered into a definitive agreement to acquire Vocera Communications (NYSE: VCRA) for $79.25 per share, totaling approximately $2.97 billion in equity value. The deal enhances Stryker's Medical division by integrating Vocera's innovative digital care coordination platform, which aims to alleviate caregiver burdens and improve patient outcomes. Both companies' boards have unanimously approved the transaction, expected to close in Q1 2022, with a neutral impact on Stryker's 2022 net earnings per share.

Stryker (NYSE:SYK) will host a conference call on January 27, 2022, at 4:30 p.m. ET to discuss its operating results for Q4 2021, with final results released at 4:05 p.m. the same day. Interested parties can register for the call through this link. The call will also be available via a webcast on Stryker's Investor Relations page. A replay will be accessible afterward at provided numbers with a passcode.

Stryker is a global leader in medical technology, focusing on improving healthcare outcomes through innovative products.